S A Tech Software India Regulatory Approval

S A Tech Software India Annual General Meeting

S A Tech Software India Limited conducted its Annual General Meeting on 14th September 2026. Shareholders transacted ordinary and special business items, including financial statement adoption.

S A Tech Software India Annual General Meeting

S A Tech Software India Limited has dispatched the Annual Report and Notice for its 14th Annual General Meeting to shareholders. The AGM is scheduled for September 14, 2026.

S A Tech Software India Board Meeting Outcome

S A Tech Software India Limited approved convening its 14th Annual General Meeting on September 14, 2026. The board also approved the draft Annual Report and Notice.

S A Tech Software India Management Change

Ms. Vasudha Kanade has resigned as the Internal Auditor of SA Tech Software India Limited effective August 12, 2026. The resignation is attributed to personal commitments.

S A Tech Software India H2 FY26 Results: Net Profit ₹2.8 Cr, Down 3.4% YoY

S A Tech Software India Limited reported revenue from operations of ₹62.6 Cr (+29.1% YoY) and net profit of ₹2.8 Cr (-3.4% YoY) for H2 FY26.

Key figure

Net profit ₹2.8 Cr · -3.4% YoY

S A Tech Software India Management Change

S A Tech Software India Ltd announced the CEO and a director resigned, and appointed a new CEO and four directors. The changes reflect leadership renewal for shareholders.

RNFI Services Regulatory Approval

RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr